CRAVES FRED B has filed 42 insider transactions across 1 company since May 2024.
Most recent transaction: a option exercise of 1728 shares of MADRIGAL PHARMACEUTICALS, INC. ($MDGL) on March 12, 2025.
Activity breakdown: 0 open-market purchases and 27 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Director | M | Common Stock | 1728 | $65.06 | 385,275.0000 | 22,080,246 | 0.45% | 0.01% |
| March 12, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Director | M | Common Stock | 6000 | $111.06 | 391,275.0000 | 22,080,246 | 1.56% | 0.03% |
| March 12, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Director | S | Common Stock | 1587 | $330.54 | 389,688.0000 | 22,080,246 | 0.41% | 0.01% |
| March 12, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Director | S | Common Stock | 2759 | $331.36 | 386,929.0000 | 22,080,246 | 0.71% | 0.01% |
| March 12, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Director | S | Common Stock | 2382 | $332.38 | 384,547.0000 | 22,080,246 | 0.62% | 0.01% |
| March 12, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Director | S | Common Stock | 800 | $333.66 | 383,747.0000 | 22,080,246 | 0.21% | 0.00% |
| March 12, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Director | S | Common Stock | 200 | $334.97 | 383,547.0000 | 22,080,246 | 0.05% | 0.00% |
| March 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Director | M | Common Stock | 7742 | $65.06 | 391,289.0000 | 22,080,246 | 2.02% | 0.04% |
| March 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Director | S | Common Stock | 1951 | $322.45 | 389,338.0000 | 22,080,246 | 0.50% | 0.01% |
| March 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Director | S | Common Stock | 1649 | $323.47 | 387,689.0000 | 22,080,246 | 0.42% | 0.01% |
| March 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Director | S | Common Stock | 900 | $324.69 | 386,789.0000 | 22,080,246 | 0.23% | 0.00% |
| March 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Director | S | Common Stock | 800 | $325.63 | 385,989.0000 | 22,080,246 | 0.21% | 0.00% |
| March 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Director | S | Common Stock | 1000 | $327.63 | 384,989.0000 | 22,080,246 | 0.26% | 0.00% |
| March 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Director | S | Common Stock | 400 | $328.68 | 384,589.0000 | 22,080,246 | 0.10% | 0.00% |
| March 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Director | S | Common Stock | 967 | $329.86 | 383,622.0000 | 22,080,246 | 0.25% | 0.00% |
| March 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Director | S | Common Stock | 75 | $330.23 | 383,547.0000 | 22,080,246 | 0.02% | 0.00% |
| March 12, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Director | M | Stock Option (Right to Buy) | 1728 | $0.00 | 7,742.0000 | 22,080,246 | 18.25% | 0.01% |
| March 12, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Director | M | Stock Option (Right to Buy) | 6000 | $0.00 | 0.0000 | 22,080,246 | 100.00% | 0.03% |
| March 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Director | M | Stock Option (Right to Buy) | 7742 | $0.00 | 0.0000 | 22,080,246 | 100.00% | 0.04% |
| Dec. 3, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Director | S | Common Stock | 3080 | $315.21 | 384,067.0000 | 0 | 0.80% | 0.00% |
| Dec. 3, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Director | S | Common Stock | 520 | $315.90 | 383,547.0000 | 0 | 0.14% | 0.00% |
| Nov. 25, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Director | S | Common Stock | 2200 | $350.08 | 388,347.0000 | 0 | 0.56% | 0.00% |
| Nov. 25, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Director | S | Common Stock | 1200 | $350.71 | 387,147.0000 | 0 | 0.31% | 0.00% |
| Sept. 13, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Not found | G | Common Stock | 15000 | $0.00 | 390,547.0000 | 0 | 3.70% | 0.00% |
| June 25, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Not found | A | Common Stock | 714 | $0.00 | 405,547.0000 | 0 | 0.18% | 0.00% |
| June 25, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Not found | A | Stock Option (Right to Buy) | 1105 | $0.00 | 1,105.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Not found | G | Common Stock | 39000 | $0.00 | 404,833.0000 | 0 | 8.79% | 0.00% |
| June 11, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Not found | G | Common Stock | 45852 | $0.00 | 404,833.0000 | 0 | 10.17% | 0.00% |
| May 14, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Not found | M | Common Stock | 10000 | $100.45 | 499,685.0000 | 0 | 2.04% | 0.00% |
| May 14, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Not found | M | Common Stock | 12489 | $105.08 | 512,174.0000 | 0 | 2.50% | 0.00% |
| May 14, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Not found | S | Common Stock | 8827 | $210.99 | 503,347.0000 | 0 | 1.72% | 0.00% |
| May 14, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Not found | S | Common Stock | 5009 | $211.84 | 498,338.0000 | 0 | 1.00% | 0.00% |
| May 14, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Not found | S | Common Stock | 1363 | $212.85 | 496,975.0000 | 0 | 0.27% | 0.00% |
| May 14, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Not found | S | Common Stock | 2190 | $213.85 | 494,785.0000 | 0 | 0.44% | 0.00% |
| May 14, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Not found | S | Common Stock | 1804 | $214.68 | 492,981.0000 | 0 | 0.36% | 0.00% |
| May 14, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Not found | S | Common Stock | 375 | $216.08 | 492,606.0000 | 0 | 0.08% | 0.00% |
| May 14, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Not found | S | Common Stock | 721 | $216.98 | 491,885.0000 | 0 | 0.15% | 0.00% |
| May 14, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Not found | S | Common Stock | 1100 | $217.86 | 490,785.0000 | 0 | 0.22% | 0.00% |
| May 14, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Not found | S | Common Stock | 1000 | $218.99 | 489,785.0000 | 0 | 0.20% | 0.00% |
| May 14, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Not found | S | Common Stock | 100 | $219.90 | 489,685.0000 | 0 | 0.02% | 0.00% |
| May 14, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Not found | M | Stock Option (right to buy) | 10000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 14, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | CRAVES FRED B | Not found | M | Stock Option (right to buy) | 12489 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |